Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Alvarez

Showing results (341-350 of 382) with videos related to

Pageof 39
Sort By:
Haematologica|May 14, 2016
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutationAlberto Alvarez-Larrán, Arturo Pereira, Paola Guglielmelli, et al.
Annals of Hematology|February 4, 2018
Prognostic risk models for transplant decision-making in myelofibrosisJuan-Carlos Hernández-Boluda, Arturo Pereira, Juan-Gonzalo Correa, et al.
American Journal of Hematology|August 30, 2023
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO studyGiovanni Paolo Maria Zambrotta, Franck E Nicolini, Sarit Assouline, et al.
Allergy|December 2, 2023
Telemedicine with special focus on allergic diseases and asthma-Status 2022: An EAACI position paperSylwia Smolinska, Florin-Dan Popescu, Elena Izquierdo, et al.
Journal for Immunotherapy of Cancer|January 13, 2026
Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasmsCecilia Pesini, Mario Gil-Bellido, Lorena S Millan, et al.
Leukemia|May 20, 2021
Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patientsTiziano Barbui, Valerio De Stefano, Alessandra Carobbio, et al.
British Journal of Haematology|August 4, 2020
Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential ThrombocythaemiaAlberto Alvarez-Larrán, Anna Angona, Marcio Andrade-Campos, et al.
Gastrointestinal Endoscopy|October 2, 2012
Initial experience with EUS-guided cholangiopancreatography for biliary and pancreatic duct drainage: a Spanish national surveyJuan J Vila, Manuel Pérez-Miranda, Enrique Vazquez-Sequeiros, et al.
The Lancet. Gastroenterology & Hepatology|September 21, 2023
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trialJohn V Reynolds, Shaun R Preston, Brian O'Neill, et al.
Hemasphere|July 21, 2023
Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential ThrombocythemiaAlberto Alvarez-Larrán, Beatriz Cuevas, Patricia Velez, et al.
Pageof 39

Showing results (341-350 of 382) with videos related to

Sort By:
Pageof 39
Haematologica|May 14, 2016
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutationAlberto Alvarez-Larrán, Arturo Pereira, Paola Guglielmelli, et al.
Annals of Hematology|February 4, 2018
Prognostic risk models for transplant decision-making in myelofibrosisJuan-Carlos Hernández-Boluda, Arturo Pereira, Juan-Gonzalo Correa, et al.
American Journal of Hematology|August 30, 2023
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO studyGiovanni Paolo Maria Zambrotta, Franck E Nicolini, Sarit Assouline, et al.
Allergy|December 2, 2023
Telemedicine with special focus on allergic diseases and asthma-Status 2022: An EAACI position paperSylwia Smolinska, Florin-Dan Popescu, Elena Izquierdo, et al.
Journal for Immunotherapy of Cancer|January 13, 2026
Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasmsCecilia Pesini, Mario Gil-Bellido, Lorena S Millan, et al.
Leukemia|May 20, 2021
Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patientsTiziano Barbui, Valerio De Stefano, Alessandra Carobbio, et al.
British Journal of Haematology|August 4, 2020
Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential ThrombocythaemiaAlberto Alvarez-Larrán, Anna Angona, Marcio Andrade-Campos, et al.
Gastrointestinal Endoscopy|October 2, 2012
Initial experience with EUS-guided cholangiopancreatography for biliary and pancreatic duct drainage: a Spanish national surveyJuan J Vila, Manuel Pérez-Miranda, Enrique Vazquez-Sequeiros, et al.
The Lancet. Gastroenterology & Hepatology|September 21, 2023
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trialJohn V Reynolds, Shaun R Preston, Brian O'Neill, et al.
Hemasphere|July 21, 2023
Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential ThrombocythemiaAlberto Alvarez-Larrán, Beatriz Cuevas, Patricia Velez, et al.
Pageof 39